Frank Barry has been named to the scientific advisory board of Toronto-based ChondroGene. He holds a PhD in biochemistry from the National University of Ireland, University College, Cork, where he also received a MSc and BSc. He is director of arthritis research at Osiris Therapeutics.
Aled Edwards has been named chief executive officer of the Structural Genomics Consortium, a UK-Canada collaboration. Edwards will continue to work with Affinium Pharmaceuticals as scientific advisor.